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Background: Reduction of pancreatic β-cells mass, major secondary to increased β-cells apoptosis, is increasingly
recognized as one of the main contributing factors to the pathogenesis of type 2 diabetes (T2D), and saturated free
fatty acid palmitate has been shown to induce endoplasmic reticulum (ER) stress that may contribute to promoting
β-cells apoptosis. Recent literature suggests that valproate, a diffusely prescribed drug in the treatment of epilepsy
and bipolar disorder, can inhibit glycogen synthase kinase-3β (GSK-3β) activity and has cytoprotective effects in
neuronal cells and HepG2 cells. Thus, we hypothesized that valproate may protect INS-1 β-cells from
palmitate-induced apoptosis via inhibiting GSK-3β.
Results: Valproate pretreatment remarkable prevented palmitate-mediated cytotoxicity and apoptosis (lipotoxicity)
as well as ER distension. Furthermore, palmitate triggered ER stress as evidenced by increased mRNA levels of C/EBP
homologous protein (CHOP) and activating transcription factor 4 (ATF4) in a time-dependent fashion. However,
valproate not only reduced the mRNA and protein expression of CHOP but also inhibited GSK-3β and caspase-3
activity induced by palmitate, whereas, the mRNA expression of ATF4 was not affected. Interestingly, TDZD-8, a
specific GSK-3β inhibitor, also showed the similar effect on lipotoxicity and ER stress as valproate in INS-1 cells.
Finally, compared with CHOP knockdown, valproate displayed better cytoprotection against palmitate.
Conclusions: Valproate may protect β-cells from palmitate-induced apoptosis and ER stress via GSK-3β inhibition,
independent of ATF4/CHOP pathway. Besides, GSK-3β, rather than CHOP, may be a more promising therapeutic
target for T2D.
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Type 2 diabetes (T2D) is a major cause of morbidity and
mortality, decreasing both the quality of life and life ex-
pectancy. Modern lifestyles, characterized by the over con-
sumption of high-calorie and high-fat food which is rich
in the saturated free fatty acid palmitate (C16 : 0) and re-
duced physical activity, have dramatically boosted the rate
of T2D [1-3]. Insulin resistance has long been regarded as
a central factor for its development. Recently, reduction of
β-cells mass, mainly due to increased apoptosis, is increas-
ingly recognized as one of the key contributing factors to* Correspondence: xpluo@tjh.tjmu.edu.cn
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unless otherwise stated.the pathogenesis of T2D [4,5]. However, the precise mech-
anisms of β-cells apoptosis are not well established.
The endoplasmic reticulum (ER) is a highly dynamic or-
ganelle with a central role in lipid and protein biosynthesis
and Ca2+ storage. Knowing the importance of ER for nor-
mal cellular function, the maintenance of ER homeostasis is
essential to cell survival. Loss of homeostasis activates an
adaptive response, which is called unfolded protein re-
sponse (UPR), also known as ER stress. However, if homeo-
stasis fails to be restored, the ER stress would initiate
apoptosis pathways [6]. β-cells, due to their heavy engage-
ment in insulin secretion, have been found to be very sensi-
tive to disruptions in ER homeostasis [7,8], and accumulating
evidence suggests that saturated free fatty acids (FFAs),
such as palmitate, have been shown to trigger ER stress
that may contribute to promoting β-cells apoptosis [9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tional serine/threonine protein kinase, is considered as
a negative regulator of β-cells mass [10,11]. Mice with
conditional ablation of GSK-3β in β-cells results in ex-
pansion of β-cells mass accompanied by enhanced pro-
liferation and decreased apoptosis by promoting the
insulin receptor/phosphatidylinositol 3-kinase (PI3K)/
Akt signaling pathway [10]. But, the explicit mecha-
nisms that GSK-3β promotes β-cells apoptosis have not
been clearly clarified. Several groups have identified the
obligatory role of GSK-3β in ER stress-induced apop-
tosis in HepG2 cells and a variety of neuronal cells
[12-14]. While, whether GSK-3β also plays a central role
in ER stress-induced β-cells apoptosis has not been
exactly verified [15].
Valproate (VPA), the most widely used anticonvulsant
and mood-stabilizing drug like lithium, has been demon-
strated to have neuroprotective effects in neurodege-
nerative conditions [16-18]. Although the mechanisms
of action of this drug have not been yet elucidated, sev-
eral candidate pathways have been implicated, including
direct inhibition of histone deacetylases (HDAC) [19]
and GSK-3β inhibition [18,20].
In the present study, we hypothesized that valproate
may protect β-cells from palmitate-induced apoptosis
via inhibiting GSK-3β.Methods
Cell culture
Rat INS-1 pancreatic β-cells were obtained from the
China Center for Type Culture Collection and cultured
as previously described [21].Palmitate preparation
Palmitate (Sigma-Aldrich, St Louis, MO) was added to
the INS-1 cells by conjugating palmitate with fatty acid-
free bovine serum albumin (BSA), and the stock solution
of palmitate was prepared as described previously [21].
Briefly, A 5 mM palmitate/5% BSA (5 mM PA) stock so-
lution was prepared by mixing 1 ml 100 mM palmitate
with 19 ml 5.26% BSA in a 55°C water bath. During ex-
periment, 5 mM PA was diluted in RPMI 1640 without
fetal bovine serum (FBS) to desired concentrations
(palmitate: BSA: molar ratio of 6.6:1).Cell viability assay
Cell viability was measured with cell counting kit-8
(CCK-8; Beyotime, Jiangsu, China) following the manu-
facturer’s instructions. The percentage of cell viability
was calculated as follows: cell viability (%) = (OD of
treatment - OD of blank control)/(OD of control - OD
of blank control) × 100.Hoechst 33342 and propidium iodide (PI) staining
For qualitative analysis of apoptosis, the cells were washed
twice with PBS and then incubated with 10 μg/ml of
Hoechst 33342 (Sigma-Aldrich, St Louis, MO) for 10 min
at 37°C, following incubation with 10 μg/ml of PI (Sigma-
Aldrich, St Louis, MO) for 15 min at room temperature.
Images were collected on a fluorescence microscopy at
400 ×magnification (Olympus, Tokyo, Japan).Flow cytometry
Quantitative analysis of apoptosis was evaluated by flow
cytometry with Alexa Fluor® 647 Annexin V (Annexin V;
Biolegend, San Diego, CA ) and PI double staining ac-
cording to the guidelines. A total of 15,000 events were
collected and analyzed by flow cytometry (BD, San Diego,
USA). Cells that bound Annexin V but excluded PI were
considered apoptotic, and cells permeant to PI were
deemed necrotic [22].Transmission electron microscopy
The morphology of ER and apoptosis were assessed by
transmission electron microscope (TEM) as described
previously [23]. Images were collected with a FEI Tecnai
G2 12 TEM (FEI Company, Eindhoven, Netherlands).Real-time quantitative PCR
Total RNA was extracted from cultured cells with Trizol
reagent (Invitrogen) following the guidelines. Real-time
quantitative PCR (RT-PCR) was performed as previously
described [24]. Primer sequences used to amplify rat acti-
vating transcription factor 4 (ATF4) and C/EBP homo-
logous protein (CHOP) were as follows: ATF4, 5′-GAG





ward) and 5′-ATGGTGGTGAAGACGCCAGTA-3′ (re-
verse). Relative gene expression was calculated according
to the comparative threshold cycle (2−ΔΔCt) method.Western blot analysis
Cell proteins were extracted in radioimmunoprecipita-
tion assay (RIPA) lysis buffer containing phenylmethyl
sulfonylfluoride, and protein concentrations were deter-
mined by the BCA protein assay kit (Beyotime, Jiangsu,
China), according to the manufacturer’s instructions.
Western blot was performed as previously described
[24]. The following antibodies were used: CHOP, GSK-
3β, phospho-GSK-3β (Ser9), caspase-3 (Cell Signaling
Technology, Danvers, MA; 1: 1,000) and GAPDH (Santa
Cruz Biotechnology; 1: 2,000).
Figure 1 Palmitate induces INS-1 cells lipotoxicity in a time-concentration dependent fashion. INS-1 cells were treated with 0.25% BSA, 0.5%
BSA, 1.0% BSA, 0.25 mM palmitate/0.25% BSA (0.25 mM PA), 0.5 mM PA or 1.0 mM PA in medium without serum. (A) After the treatments for the times
indicated on the X-axis, cell viability was assessed by CCK-8 assay. The figure shows representative results of three independent experiments. The given
values are mean ± SD of at least five duplicate wells. **P < 0.01; §P < 0.001 vs. control (BSA groups). (B-C) After the treatments for 48 h, the cells were
stained with Annexin V and PI and assessed by flow cytometry. B shows the percentage of apoptosis. Data are mean ± SD of three independent
experiments. §P < 0.001 vs. control (BSA groups). C shows the representative result of INS-1 cells apoptosis and necrosis (1% BSA vs. 1 mM PA).
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CHOP knockdown was performed using small interfering
RNA (siRNA) in INS-1 cells. Two siRNA duplexes target-
ing encoding regions of rat CHOP and one cy3-labeled
scrambled siRNA (Mock) were designed and chemicallysynthesized (Ribobio, Canton, China). The oligonucleo-
tide sequences were as follows: siCHOP-1 (targeting se-
quence: GGCTCAAGCAGGAAATCGA), 5′-GGCUCAA
GCAGGAAAUCGAdTdT-3′ (forward), and 3′-dTdT
CCGAGUUCGUCCUUUAGCU-5′ (reverse); siCHOP-2
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CCAGAUUCCAGUCAGAGUUdTdT-3′ (forward), and
3′-dTdTGGUCUAAGGUCAGUCUCAA-5′ (reverse).
INS-1 cells were transfected with the two CHOP
siRNAs or scrambled siRNA using Lipofectamine
RNAiMAX reagent (Invitrogen, Carlsbad, CA) follow-
ing the manufacturer’s instructions. A final 50 nM
siRNA was added to INS-1 cells for 48 h, then the
efficiency of silence was assessed by RT-PCR and
Western blot.Statistical analysis
All data are presented as mean ± SD. Statistical significance
between two conditions was analyzed by the independent-
sample t-test and between three or more groups using
one-way ANOVA, where P < 0.05 was considered statisti-
cally significant.Figure 2 Effect of valproate on cell viability and palmitate-induced cy
concentrations of valproate for 24 h or 48 h, then cell viability was measur
independent experiments. The given values are mean ± SD of at least five
(B) With or without VPA pretreatment for 48 h, INS-1 cells were exposed to
The figure shows representative results of three independent experiments.
§P < 0.001 vs. 0.25 mM PA.Results
Palmitate reduces INS-1 cells survival in a time-concentration
dependent fashion, primarily due to increased β-cells
apoptosis
Palmitate has been shown to induce apoptosis in β-cells
lines, primary cultured β-cells as well as human islets
[9,22,25]. Our results revealed that 0.25-1.0 mM PA sig-
nificantly reduced cell viability (cytotoxicity) as early as
6 h treatment (P < 0.01 or P < 0.001), and the cytotoxicity
had time-concentration dependency (Figure 1A). Fur-
thermore, compared with BSA control groups, treatment
with indicated concentrations of PA for 48 h showed ap-
parently apoptosis as well as a small mount of necrosis in
a concentration-dependent manner (P < 0.001; Figure 1B
and C). Our results are consistent with the reported
findings showing that palmitate decreases the viability
of β-cells and the main factor underlying this is in-
creased β-cells apoptosis [22].totoxicity in INS-1 cells. (A) INS-1 cells were exposed to different
ed by CCK-8 assay. The figure shows representative results of three
duplicate wells. *P < 0.05; **P < 0.01; §P, βP < 0.001 vs. FBS group.
0.25 mM PA for 24 h, then cell viability was assessed by CCK-8 assay.
The given values are mean ± SD of at least five duplicate wells.
Figure 3 (See legend on next page.)
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Figure 3 Valproate pretreatment prevents palmitate-induced apoptosis and ER distension. INS-1 cells were pretreated with or without
1 mM VPA for 48 h before challenged with 0.25 mM PA. (A) After the treatments for 24 h, apoptosis was assessed by staining cells with Hoechst
33342/PI (a-c), meanwhile the morphology of INS-1 cells was also captured (d-f). Apoptosis was characterized by nucleus condensed or
fragmented (red arrows) that intensely stained with Hoechst 33342 (blue fluorescence). In each case five to seven microscopic fields were
photographed randomly. Scale bars: a-f = 400 ×magnification. (B) After the treatments for 24 h or 48 h, the cells were stained with Annexin V
and PI, and the percentage of apoptosis was detected by flow cytometry. Data are mean ± SD of three independent experiments. **P < 0.01;
§P < 0.001. (C) After the treatments for 24 h, (a-c) apoptosis and (d-f) morphology of ER were visualized by electron microscopy. The presence of
marked chromatin condensation was considered to be a sign of apoptosis. ER distension is marked with red arrows. Scale bars: a-c = 2 μm; d-f = 1 μm.
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cytotoxicity
Valproate pretreatment has exhibited cytoprotection in
neuronal cells and HepG2 cells [13,26,27]. Clinically,
total valproate serum concentrations between 0.5 mM
and 1 mM are observed to be effective in the treatment
of bipolar disorder [28]. However, the effect of valproate
on β-cells remains unknown. First, we investigated the
cytotoxic properties of valproate in β-cells and found
that concentrations of valproate below 2 mM had no
cytotoxic effect (Figure 2A). Then, to determine the ef-
fect of valproate on palmitate-induced cytotoxicity, INS-
1 cells were exposed to 0.25 mM PA with or without
pretreatment with 1 or 2 mM valproate for 48 h. Valpro-
ate pretreatment displayed a strong cytoprotective effect
against palmitate-induced toxicity (P < 0.001), and there
was no significant difference between 1 mM and 2 mM
valproate groups. While, without pretreatment, valproate
hardly revealed any cytoprotection against palmitate-
induced toxicity (Figure 2B).
Valproate pretreatment protects INS-1 cells from
palmitate-induced apoptosis and ER distension
To investigate the influence of valproate on palmitate-
induced apoptosis and ER distension, we evaluated
apoptosis by fluorescence microscope. Consistent with
our previous results, palmitate-treated cells displayed
the characteristic features of apoptosis, including nuclei
appeared smaller or fragmented into apoptotic bodies
(Figure 3A), while necrosis was rarely observed (data
not shown). At the same time, the morphology of
the palmitate-treated cells was also abnormal as the
cells appeared condensed and angular. Whereas, valpro-
ate pretreatment alleviated palmitate-induced apoptosis
and ameliorated the morphology (Figure 3A). Next, we
carried out quantitative analysis of apoptosis by flow cy-
tometry and further confirmed that valproate pretreat-
ment significantly decreased the sensitivity of INS-1 cells
to palmitate-induced apoptosis (P < 0.01; Figure 3B).
Then we observed the morphology of ER and apop-
tosis by electron microscopy. Palmitate-treated cells ex-
hibited marked chromatin condensation, an indication
of apoptosis. Meanwhile, we observed electron-lucent
clefts extending throughout the cytoplasm which werecontinuous with abnormal nuclear envelope, suggesting
that ER appears distended in the process of palmitate-
induced INS-1 cells apoptosis. As expected, we rarely
observed apoptosis and dilated ER in valproate pretreat-
ment group (Figure 3C). These findings are consistent
with our previous results and further support the hy-
pothesis that valproate treatment increases the resistance
of INS-1 cells to palmitate-induced apoptosis as well as
ER distension.
Valproate ameliorates palmitate-induced caspase-3
dependent apoptosis by GSK-3β inhibition
Valproate has been identified to directly and efficiently in-
hibit GSK-3β [13,18]. We hypothesized that valproate may
protect β-cells from palmitate-induced apoptosis via in-
hibiting GSK-3β. Our results showed that valproate pre-
treatment decreased palmitate-induced cleaved caspase-3
protein expression, as well as GSK-3β activation by in-
creasing phosphorylation of Ser9 (P < 0.01; Figure 4A),
suggesting that GSK-3β is involved in palmitate-induced β-
cells apoptosis, which is likely to be caspase-3 dependent.
Additionally, valproate may prevent palmitate-induced β-
cells apoptosis via GSK-3β inhibition.
To confirm the cytoprotection of GSK-3β inhibition,
we examined the influence of two other GSK-3β inhibi-
tors, LiCl and TDZD-8, on palmitate-induced cytotox-
icity. 2 mM LiCl and 10 μM TDZD-8 had no cytotoxic
effect on INS-1 cells (Additional file 1: Figure S1).
10 μM TDZD-8, similar with valproate, had a strong
cytoprotective effect against palmitate-induced toxicity
at different time points (P < 0.001). Unexpectedly, 2 mM
LiCl partially protected against palmitate-induced cyto-
toxicity after 24 h (P < 0.001), but not after 36 or 48 h
(Figure 4B).
Valproate prevents palmitate-induced ER stress, inde-
pendent of ATF4/CHOP pathway
Valproate pretreatment could ameliorate palmitate-induced
ER distension, so we further investigated the effect of val-
proate on palmitate-induced ER stress. As expected, palmi-
tate markedly increased the mRNA expressions of ER
stress markers, ATF4 and CHOP, in a time-concentration
dependent fashion (Figure 5A, B and C). Compared with
palmitate-treated group, co-treatment with valproate and
Figure 4 Valproate pretreatment protects β-cells from palmitate-induced apoptosis via GSK-3β inhibition. (A) With presence or absence
of 1 mM VPA pretreatment, INS-1 cells were exposed to 0.25 mM PA for 48 h. The expressions of phospho-GSK-3β and cleaved caspase-3 were
detected by Western blot. GAPDH protein served as loading control. The intensity of protein bands was quantified by densitometry and expressed
as fold change compared with control. Data are mean ± SD of three independent experiments. **P < 0.01; §P < 0.001. (B) INS-1 cells were
pretreated with VPA, LiCl or TDZD-8 before challenged with 0.25 mM PA for the times indicated on the X-axis. After the treatments, cell viability
was measured by CCK-8 assay. The figure shows representative results of three independent experiments. The given values are mean ± SD of at
least five duplicate wells. §P < 0.001 vs. 0.25 mM PA; &P < 0.001 vs. 0.25 mM PA + 1 mM VPA.
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whereas, the mRNA expression of ATF4 was not influ-
enced (Figure 5A). Interestingly, in line with the effect
of valproate, TDZD-8 also only reduced palmitate-
induced CHOP mRNA expression at different time
points (P < 0.05; Figure 5B and C).
Next, we focused on whether valproate could decrease
palmitate-induced CHOP protein expression and found
that valproate pretreatment weakened palmitate-induced
CHOP protein level (P < 0.05; Figure 5D). These findings
suggest that valproate blocks palmitate-induced ER stress
by reducing CHOP expression, independent of ATF4/
CHOP pathway.
Valproate pretreatment, rather than CHOP knockdown,
prevents palmitate-induced INS-1 cells lipotoxicity
In INS-1 cells, palmitate could enhance the expression of
proapoptotic marker CHOP, and valproate could down-
regulate palmitate-induced CHOP expression. We further
investigated whether CHOP plays an important role in
palmitate-induced INS-1 cells apoptosis by siRNA. Trans-
fecting with two different CHOP siRNAs for 48 h, we
obtained 70%-80% inhibition of CHOP in mRNA andprotein levels compared with control group, and the inhib-
ition was more prominent when co-transfected with both
of the two CHOP siRNAs (Figure 6A and B). Conse-
quently, the two CHOP siRNAs co-transfection were de-
livered in the following experiments.
50 nM CHOP siRNAs has no cytotoxic effect on INS-1
cells, and our results showed that CHOP siRNAs pro-
tected against palmitate-induced cytotoxicity after 24 h
(P < 0.05), but not after 48 h treatment (Figure 6C), indi-
cating that CHOP knockdown delays, but does not pre-
vent palmitate-induced cytotoxicity. Finally, we compared
the cytoprotection of CHOP siRNAs with valproate by
flow cytometry, and agreed with CCK-8 assay, only valpro-
ate but not CHOP siRNAs protected INS-1 cells from
palmitate-induced apoptosis after 48 h treatment (P <
0.01, Figure 6D).
Discussion
Strong evidence indicates that the global epidemic of
T2D is tied to escalating rates of obesity in adults as well
as in youths [29], and obesity, associated with elevated
levels of circulating FFAs, is a major risk factor for the
development of T2D [30]. Palmitate is one of the most
Figure 5 Valproate and TDZD-8 pretreatment ameliorate palmitate-induced ER stress by reducing CHOP expression. With presence or
absence of 1 mM VPA or 20 μM TDZD-8 pretreatment, INS-1 cells were exposed to 0.25 mM PA for 24 h (A), 0.5 mM PA for the times indicated
on the X-axis (B-C), or 0.25 mM PA for 48 h (D). After the treatments, the expressions of ATF4 and CHOP mRNA (A-C) and CHOP protein level
(D) were detected by RT-PCR and Western blot, respectively. The intensity of protein bands was quantified by densitometry. Results are presented
as fold change compared with control. Data are mean ± SD of three independent experiments. *P < 0.05; **P < 0.01; §P < 0.001.
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plasma and tissue lipids [3], furthermore, several studies
have demonstrated that saturated FFAs such as palmitate
induce β-cells apoptosis, which is increasingly recognized
as one of the main influence factors to the pathogenesis
of T2D [4,5,9,22]. Our study confirmed that treatment
with 0.25-1.0 mM palmitate for 6–48 h reduced INS-1
cells survival in a time-concentration dependent manner,
largely due to enhanced β-cells apoptosis.
GSK-3β is considered as a promoter of β-cells apop-
tosis [10], but the explicit mechanisms that GSK-3β pro-
motes β-cells apoptosis have not been clearly elucidated.
Several groups have identified that GSK-3β is involved
in ER stress-induced apoptosis in a variety of cells, in-
cluding neuronal cells, HepG2 cells and mouse insuli-
noma (MIN6) cells [12-15]. Furthermore, valproate has
been identified to protect HepG2 cells from tunicamycin
or A23187 induced apoptosis partly mediated by directly
inhibiting GSK-3β [13]. In the present study, we exam-
ined whether valproate protects β-cells from palmitate-
induced apoptosis via GSK-3β inhibition.
Our results showed that only valproate pretreatment
revealed a strong cytoprotective effect against palmitate-
induced toxicity. According to the reported findings, thepossible reason that the cytoprotection of valproate re-
quires extended pretreatment is that the effect of valproate
has time dependency in a certain time [27]. In addition,
we found that valproate pretreatment, at clinically relevant
doses, protected INS-1 cells from palmitate-induced apop-
tosis as well as ER distension, which may be an indicator
of ER stress. Meanwhile, co-treatment with valproate
and palmitate significantly decreased palmitate-induced
caspase-3 activation as well as GSK-3β activation. Our re-
sults suggest that GSK-3β is involved in palmitate-induced
caspase-3 dependent apoptosis in INS-1 cells, whereas val-
proate may protect INS-1 cells from palmitate-induced
apoptosis via GSK-3β inhibition.
If valproate could protect INS-1 cells from palmitate-
induced dysfunction by virtue of its ability to inhibit GSK-
3β, then other inhibitors of GSK-3β should confer similar
protection. As expected, TDZD-8, a specific GSK-3β in-
hibitor, also showed prominent cytoprotective effect
against palmitate-induced cytotoxicity. Whereas, LiCl only
partially protected against palmitate-induced cytotoxic ef-
fect in INS-1 cells. This result is somewhat different from
several reported findings that 10 or 20 mM LiCl have
cytoprotective properties against an array of insults in
neuroblastoma cells and preadipocytes [31,32]. Although
Figure 6 Valproate pretreatment, rather than CHOP knockdown, prevents palmitate-induced INS-1 cells lipotoxicity. (A-B) INS-1 cells
were transfected with siCHOP for 48 h, the expressions of CHOP mRNA and protein were detected by RT-PCR and Western blot, respectively.
Results are shown as fold change compared with control. Data are mean ± SD of three independent experiments. §P < 0.001 vs. control. (C) INS-1
cells were transfected with 50nM CHOP siRNAs for 48 h, then exposed to 0.25 mM PA for 24 h or 48 h. After the treatments, cell viability was
assessed by CCK-8 assay. The figure shows representative results of three independent experiments. The given values are mean ± SD of at least
five duplicate wells. *P < 0.05; §P < 0.001. (D) INS-1 cells were exposed to conditions indicated on the X-axis for 48 h. After the treatments, the
percentage of apoptosis was measured by flow cytometry. Data are mean ± SD of three independent experiments. **P < 0.01.
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cell types and cellular stresses [33]. The other possible rea-
son is that the ability of GSK-3β inhibition of LiCl has
concentration dependency. Because LiCl has cytotoxic ef-
fect on INS-1 cells at a lower concentration, and apparent
toxicity was observed at concentrations over 10 mM. We
performed the pretreatment with 2 mM LiCl, while 2 mM
LiCl may not be effective to inhibit GSK-3β in INS-1 cells.
Furthermore, compared with LiCl, valproate is a more ef-
fective inhibitor of GSK-3β [13]. Together these results
suggest that GSK-3β plays a critical role in palmitate-
induced β-cells apoptosis, furthermore, GSK-3β inhibition
could be one of the main mechanisms that valproate pre-
vents palmitate-induced apoptosis in INS-1 cells. How-
ever, according to the present study, we cannot exclude
the possibility that HDAC inhibition or other effects con-
tribute to the observed cytoprotective effect of valproate.
ER stress is a double-edged sword. When homeostasis
is disturbed, ER stress has three master transducers
which serve to mitigate stress: inositol requiring enzyme 1
(IRE1), activating transcription factor 6 (ATF6), and PKR-
like ER kinase (PERK). In PERK branch, the persistent
phosphorylation of eukaryotic translation initiation factor
2α (eIF2α) by PERK increases CHOP expression via ATF4.
However, if homeostasis fails to be maintained, the ERstress would trigger apoptosis [6]. To date, several proteins
involved in ER stress-induced apoptosis have been identi-
fied, including CHOP, c-Jun NH2-terminal kinase (JNK),
and caspase-12 [7]. Furthermore, proapoptotic marker
CHOP plays an important role in palmitate-induced β-
cells apoptosis, which is mainly dependent on PERK path-
way [9,34,35].
Although some groups have identified the obligatory
role of GSK-3β in ER stress-induced apoptosis, the effects
of GSK-3β on ER stress are inconsistent. In neuronal cells,
the GSK-3β inhibitor LiCl strongly attenuates CHOP ex-
pression induced by ER stress agent tunicamycin treat-
ment, but the mechanism by which GSK-3β regulates
CHOP expression does not involve regulation of the two
most prominent transcription factors that can induce
CHOP, ATF4 and ATF6 [14], while in HepG2 cells and
MIN6 cells, down-regulation of GSK-3β prevents cells
from ER stress-induced apoptosis without altering the
level of ER stress proapoptotic marker CHOP [13,15].
In the current study, we confirmed that ER stress con-
tributed to palmitate-induced caspase-3 dependent apop-
tosis in INS-1 cells. The PERK pathway was activated as
evidence that the mRNA expressions of ATF4 and CHOP
were significant up-regulated by palmitate in a time-
concentration dependent manner. Interestingly, compared
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valproate or TDZD-8 before challenge with palmitate sig-
nificantly decreased CHOP level, whereas, the expression
of ATF4 was not affected. Our results suggest that valpro-
ate and TDZD-8 prevent palmitate-induced ER stress by
reducing CHOP expression, independent of ATF4/CHOP
pathway.
In addition, according to our results, we speculated
that GSK-3β is upstream of ER stress-induced CHOP
expression in INS-1 cells. Though GSK-3β may promote
palmitate-induced ER stress via CHOP, up-regulation of
CHOP expression cannot be the only mechanism that
GSK-3β promotes the apoptosis during palmitate treat-
ment, because CHOP knockdown delayed, but did
not prevent palmitate-induced cytotoxicity. Furthermore,
compared with CHOP knockdown, valproate displayed
better cytoprotection against palmitate. Thus, we deduced
that GSK-3β rather than CHOP may be a more efficient
target to prevent palmitate-induced apoptosis. Neverthe-
less, how GSK-3β facilitates apoptosis remains unclear,
several candidate pathways have been involved, including
p53, pancreas/duodenum homeobox protein-1 (PDX-1),
heat shock factor-1 (HSF-1), eukaryotic initiation factor
2B (eIF2B) and cyclic AMP response element-binding pro-
tein (CREB) [10,36-38].
Conclusions
In summary, our work suggests that both GSK-3β and ER
stress are involved in palmitate-induced caspase-3 de-
pendent apoptosis in INS-1 cells. Valproate, at clinically
relevant doses, may protect β-cells from palmitate-induced
apoptosis and ER stress via GSK-3β inhibition, independ-
ent of ATF4/CHOP pathway. Besides, GSK-3β, rather than
CHOP, may be a more promising therapeutic target for
T2D. Further studies will be required in different types of
β-cells and in animal models to explore the potential effi-
cacy of GSK-3β on β-cells apoptosis and the explicit mech-
anisms that GSK-3β promotes β-cells apoptosis.
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